bringing you the latest and original global medtech industry dynamics
As of 2021, there was a total of 1,030,935 healthcare institutions in China including 36,570 hospitals, 977,790 grassroots healthcare institutions, and 13,276 specialized public healthcare institutions
Read More
In healthcare, no two digital transformations are alike, and this message comes across loud and clear from health informatics leaders
Read More
Large medtech companies are struggling with growth challenges and stagnant valuations. Could M&A and divestitures reset the trajectory?
Read More
Industry leaders in medtech experienced significant market transformation during 2021, precipitated by events related to ongoing structural changes within healthcare, the evolution and juxtaposition of various technological innovations,
Read More
directly engaging with referring physicians in an office-based setting is out of most medtech companies’ comfort zones, and significant effort is often required to convince a fragmented and dispersed audience of healthcare professionals to adopt a new therapy
Read More The survey paints a picture of hospitals in the region that are getting back to normal operations – and resuming expansion – after two years of pandemic disruption.
Read More
To leverage the digital opportunity fully and create transformative change, health care innovators must address needs across the patient journey.
Read More
To rise to the occasion, leading companies are leveraging technology-driven supply chain models (AI, cloud and IoT enabled) with end-to-end digitized and transformed processes that leverage data and analytics at scale
Read More volume-based procurement aims to lower the price of medical consumables by tendering the market volume of cities, provinces or the country to manufacturers with the lowest price
Read More
Record-high valuations are forcing acquirers to get creative
Read More
English (UK) 
简体中文 
Deutsch 
Français 
Español 
Português 
Italiano 
Nederlands